Alexion Pharmaceuticals, Inc. Financial Statements 2011-2024 | ALXN

	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	33.6 B	22.4 B	27 B	27.4 B	28.7 B	31.1 B	36.3 B	31.7 B	18.2 B	13.7 B
Shares	219 M	223 M	223 M	224 M	224 M	213 M	198 M	196 M	190 M	183 M
Net Income	603 M	2.4 B	77.6 M	443 M	399 M	144 M	657 M	253 M	255 M	175 M
Revenue	6.07 B	4.99 B	4.13 B	3.55 B	3.08 B	2.6 B	2.23 B	1.55 B	1.13 B	783 M
EBITDA	3.11 B	2.45 B	1.91 B	1.12 B	1.12 B	799 M	963 M	567 M	454 M	245 M
Operating Expenses	2.66 B	2.46 B	2.16 B	2.29 B	2.03 B	1.69 B	1.14 B	807 M	608 M	446 M
General and Administrative Expenses	1.4 B	1.26 B	1.11 B	1.09 B	954 M	863 M	630 M	490 M	385 M	308 M